Humana (HUM)
(Delayed Data from NYSE)
$279.45 USD
-37.29 (-11.77%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $278.50 -0.95 (-0.34%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$279.45 USD
-37.29 (-11.77%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $278.50 -0.95 (-0.34%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Zacks News
Community Health Sells Byrd Regional & Tennova Healthcare
by Zacks Equity Research
Community Health (CYH) recently closes the sale of 60-bed Byrd Regional Hospital and its associated assets besides the 85-bed Tennova Healthcare.
Humana (HUM) Up 3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Research Reports for Facebook, Intel & Boeing
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Intel (INTC) and Boeing (BA).
8 Solid Reasons to Retain United Health in Your Portfolio
by Zacks Equity Research
Riding high on eight important factors, United Health (UHS) holds great potential to generate lucrative returns to investors.
UnitedHealth Extends LabCorp Ties, Signs Quest Diagnostic Deal
by Zacks Equity Research
UnitedHealth (UNH) agrees with laboratories and diagnostic companies for value based care.
Centene Banks on Investments and Acquisitions for Growth
by Zacks Equity Research
Centene???s (CNC) numerous acquisitions and investments poise it well for inorganic growth.
Zacks Industry Outlook Highlights: UnitedHealth, Anthem, Aetna, Cigna and Humana
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth, Anthem, Aetna, Cigna and Humana
Tenet (THC) Hits 52-Week High on Solid Q1, Raises'18 View
by Zacks Equity Research
Riding high on better-than-expected first-quarter results and a rating upgrade, Tenet (THC) touches a 52 week-high in yesterday's trading session.
5 Reasons Why You Must Add Humana (HUM) to Your Portfolio
by Zacks Equity Research
Humana (HUM) looks promising to garner better returns for investors owing to five factors.
Triple-S Management (GTS) Soars to a 52-Week High, Time to Cash Out?
by Zacks Equity Research
Triple-S Management Corporation is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for GTS for clues.
Top Research Reports for General Dynamics, Enbridge & CSX Corporation
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including General Dynamics (GD), Enbridge (ENB) and CSX Corporation (CSX).
5 Reasons to Add WellCare Health Plans to Your Portfolio
by Zacks Equity Research
WellCare Health Plans (WCG) looks lucrative, promising better yield for investors on the back of five factors.
Here's Why Teladoc Reaches a 52 Week High, Stock Up 22%
by Zacks Equity Research
Teladoc's (TDOC) robust results and a favorable guidance increase the stock price.
Humana (HUM) Tops Q1 Earnings and Revenues, Lifts Guidance
by Zacks Equity Research
Humana's (HUM) Q1 draws stength from Medicare Advantage enrollment growth, solid segmental performances, lower taxes as well as a favorable impact of share buybacks.
Humana's (HUM) Q1 Earnings Top Estimates, Raises Guidance
by Zacks Equity Research
Humana's (HUM) Q1 earnings reflect Medicare Advantage enrollment growth and solid performance across all segments.
Why Humana Inc. (HUM) Might Surprise This Earnings Season
by Zacks Equity Research
Humana (HUM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.
Humana (HUM) Q1 Earnings to Benefit From Medicare Business
by Zacks Equity Research
Humana (HUM) Q1 earnings should see upside from higher revenues in Retail segment, but investments may increase total expenses.
Will Teladoc (TDOC) Q1 Earnings Buoy On Severe Flu Season?
by Zacks Equity Research
We expect Teladoc's (TDOC) earnings to see an upside from the recent severe flu season,which should lead to higher patient visits.
Will Higher Medicare Revenues Aid Aetna (AET) Q1 Earnings?
by Zacks Equity Research
Aetna (AET) Q1 earnings should benefit from growth in its Medicare business and a lower tax rate, partly offset by a decline in revenues.
HCA Healthcare (HCA) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
HCA Healthcare (HCA) Q1 results should see an upside from flu-related activity and lower taxes, partly offset by pressure on volumes.
Tenet Healthcare's (THC) Q1 Earnings: Is a Beat in Store?
by Zacks Equity Research
Tenet Healthcare's (THC) earnings are likely to beat estimates in the first quarter, riding high on the robust performance of its Ambulatory segment.
Company News for Apr 24, 2018
by Zacks Equity Research
Companies in the news are: ALK,ASB,HSIC,HUM
Anthem (ANTM) Q1 Earnings: What's in Store for the Stock?
by Zacks Equity Research
Anthem's (ANTM) first-quarter earnings might gain from a solid Government business. However, persistent softness in Individual business is likely to affect overall results.
Can Government Business Drive Centene's (CNC) Q1 Earnings?
by Zacks Premium Research
Centene's (CNC) first quarter 2018 results are likely to benefit from Medicaid expansion as well as rising participation in exchanges.
UnitedHealth (UNH) Q1 Earnings & Revenues Top, View Lifted
by Zacks Equity Research
UnitedHealth (UNH) Q1 earnings reflect double-digit growth across each business line.